HCM
Harvey Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.28M | Sell |
11,742
-1,350
| -10% | -$722K | 1.47% | 19 |
|
|
2025
Q1 | $8.3M | Buy |
13,092
+28
| +0.2% | +$17.8K | 2.17% | 13 |
|
|
2024
Q4 | $9.31M | Buy |
13,064
+242
| +2% | +$172K | 2.19% | 9 |
|
|
2024
Q3 | $13.5M | Sell |
12,822
-35
| -0.3% | -$36.8K | 3.37% | 7 |
|
|
2024
Q2 | $13.5M | Sell |
12,857
-70
| -0.5% | -$73.6K | 3.55% | 6 |
|
|
2024
Q1 | $12.4M | Sell |
12,927
-77
| -0.6% | -$74.1K | 3.64% | 6 |
|
|
2023
Q4 | $11.4M | Sell |
13,004
-127
| -1% | -$112K | 3.79% | 7 |
|
|
2023
Q3 | $10.8M | Sell |
13,131
-30
| -0.2% | -$24.7K | 3.8% | 7 |
|
|
2023
Q2 | $9.46M | Buy |
13,161
+581
| +5% | +$417K | 3.48% | 7 |
|
|
2023
Q1 | $10.3M | Sell |
12,580
-140
| -1% | -$115K | 4.07% | 7 |
|
|
2022
Q4 | $9.18M | Sell |
12,720
-10
| -0.1% | -$7.22K | 3.84% | 6 |
|
|
2022
Q3 | $8.77M | Sell |
12,730
-3,080
| -19% | -$2.12M | 3.8% | 6 |
|
|
2022
Q2 | $9.35M | Sell |
15,810
-1,083
| -6% | -$640K | 3.64% | 6 |
|
|
2022
Q1 | $11.8M | Buy |
16,893
+98
| +0.6% | +$68.4K | 3.64% | 7 |
|
|
2021
Q4 | $10.6M | Buy |
16,795
+1,033
| +7% | +$652K | 3.29% | 8 |
|
|
2021
Q3 | $9.54M | Sell |
15,762
-1,400
| -8% | -$847K | 3.27% | 8 |
|
|
2021
Q2 | $9.59M | Buy |
17,162
+6,105
| +55% | +$3.41M | 3.16% | 9 |
|
|
2021
Q1 | $5.23M | Buy |
+11,057
| New | +$5.23M | 1.9% | 19 |
|
|
2020
Q4 | – | Sell |
-400
| Closed | -$223K | – | 81 |
|
|
2020
Q3 | $223K | Sell |
400
-50
| -11% | -$27.9K | 0.1% | 70 |
|
|
2020
Q2 | $280K | Buy |
+450
| New | +$280K | 0.14% | 61 |
|